EPHX2 and atherosclerosis: Consistently, either specific expression of CYP2J2 in ApoE−/− mice or pharmacological inhibition of sEH significantly increased levels of EETs in mice and subsequently delayed the progression of atherosclerosis by decreasing the expression of adhesion molecules and the level of inflammatory cytokines [68,69,70].